Daniil Gataulin
Stock Analyst at Chardan Capital
(4.67)
# 175
Out of 4,974 analysts
106
Total ratings
57.29%
Success rate
38.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QURE uniQure | Maintains: Buy | $35 | $17.95 | +94.99% | 6 | Aug 29, 2025 | |
| OTLK Outlook Therapeutics | Maintains: Neutral | $3 | $0.94 | +220.86% | 10 | Aug 28, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $11.18 | +445.62% | 6 | Aug 15, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $2.20 | +354.55% | 1 | Aug 15, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $35 | $7.71 | +354.25% | 5 | Aug 15, 2025 | |
| TRML Tourmaline Bio | Maintains: Buy | $70 | $26.74 | +161.78% | 3 | Aug 14, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $33 | $3.52 | +837.50% | 8 | Aug 13, 2025 | |
| CRVO CervoMed | Maintains: Buy | $15 | $10.51 | +42.72% | 7 | Aug 11, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $9.71 | +435.53% | 12 | Aug 8, 2025 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $4 | $2.61 | +53.26% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $14.01 | +92.72% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 | $1.03 | +579.61% | 13 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.35 | - | 5 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $33 | $17.16 | +92.31% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $0.66 | +33,233.33% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.52 | - | 2 | Jul 25, 2023 |
uniQure
Aug 29, 2025
Maintains: Buy
Price Target: $35
Current: $17.95
Upside: +94.99%
Outlook Therapeutics
Aug 28, 2025
Maintains: Neutral
Price Target: $3
Current: $0.94
Upside: +220.86%
Forte Biosciences
Aug 15, 2025
Maintains: Buy
Price Target: $61
Current: $11.18
Upside: +445.62%
Zura Bio
Aug 15, 2025
Maintains: Buy
Price Target: $10
Current: $2.20
Upside: +354.55%
MeiraGTx Holdings
Aug 15, 2025
Maintains: Buy
Price Target: $35
Current: $7.71
Upside: +354.25%
Tourmaline Bio
Aug 14, 2025
Maintains: Buy
Price Target: $70
Current: $26.74
Upside: +161.78%
Adverum Biotechnologies
Aug 13, 2025
Maintains: Buy
Price Target: $33
Current: $3.52
Upside: +837.50%
CervoMed
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $10.51
Upside: +42.72%
REGENXBIO
Aug 8, 2025
Maintains: Buy
Price Target: $52
Current: $9.71
Upside: +435.53%
Cognition Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $2.61
Upside: +53.26%
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $14.01
Upside: +92.72%
Aug 4, 2025
Maintains: Buy
Price Target: $7
Current: $1.03
Upside: +579.61%
Jul 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.35
Upside: -
May 9, 2025
Maintains: Buy
Price Target: $28 → $33
Current: $17.16
Upside: +92.31%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $0.66
Upside: +33,233.33%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $10.52
Upside: -